2020 Indiana CTSI Annual Meeting poster presentation breakout rooms selected

September 3, 2020

All 2020 Indiana Clinical and Translational Sciences Institute (CTSI) Annual Meeting participants are invited to attend concurrent breakout poster sessions from 12:15 pm to 1:00 pm during the meeting on Friday, September 11. The live virtual poster presentations will occur as ten concurrent breakout rooms, with five presenters in each room.

After the presentations, the moderators will facilitate a discussion about services, training and other opportunities available through the Indiana CTSI.

The Zoom room links and passwords are listed on the annual meeting invitation, as well as hyperlinked below. The presentation times listed are approximate. The rooms will be:

  • Cell Biology & Biochemistry
    • 12:15 pm – Hanisha Battina, IU School of Medicine – Impacts of Type II Diabetes and BMP-2 in Lung Endothelial Cells for Fracture Healing (Investigator)
    • 12:21 pm – Andy Chen, PhD, IU School of Medicine – High-throughput Reporter Assay Reveals Functional Impact of 3′-UTR SNPs Associated with Neurological and Psychiatric Disorders (TL1 Postdoc)
    • 12:27 pm – Danielle Janosevic, DO, IU School of Medicine – Proximal Tubular S3 Cells Expressing Angiotensinogen Localize to the Outer Stripe of the Outer Medulla (KL2)
    • 12:33 pm – Sarah Lipp, Purdue University – Elastin-microfibril axis proteins form transient 3D structures during murine nephrogenesis (TL1 Predoc)
    • 12:39 pm – Fahmi Mesmar, PhD, Indiana University-Bloomington – Adipocyte differentiation and/or lipid accumulation are induced by commonly used pesticides in Indiana (Investigator)
  • COVID-19
    • 12:15 pm – Nathan Alves, PhD, IU School of Medicine – Real-World Implementation of UV N95 Mask Decontamination in the Hospital Setting (Investigator)
    • 12:21 pm – Jordan Hill, PhD, IU School of Medicine – Remotely Delivering a Medication Safety Intervention during a Global Pandemic (Investigator)
    • 12:27 pm – Heather Kelker, MD, IU School of Medicine – Longitudinal Emergency Medicine Provider Burnout and Wellness During the COVID-19 Pandemic (Investigator)
    • 12:33 pm – Brianna Kiefer, MS – Obtaining Objective Clinical Measures in Tele-Evaluations of Dysarthria (TL1 Predoc)
    • 12:39 pm – Cameron Snapp, IU School of Medicine – Exploratory Analysis of COVID-19 Case Demographics in Gary, Indiana (IMPRS)
  • COVID-19 & Immunology
    • 12:15 pm – Jesus Alonso, PhD, University of Notre Dame – Insights from an in vitro derived T Cell Receptor (TL1 Postdoc)
    • 12:21 pm – Grant Keller, University of Notre Dame – Determinants of Peptide-MHC Antigenicity for the Development of Personalized/Multiple Peptide Vaccines (TL1 Predoc)
    • 12:27 pm – Jake Lazarus, MHA, IU School of Medicine – The Indiana CTSI PPE Project: A Conduit Between Innovation and Need in the COVID-19 Crisis (Investigator)
    • 12:33 pm – Heidi Lindroth, PhD, RN, IU School of Medicine – Delirium Incidence, Duration and Severity in Critically Ill Patients with COVID-19 (Investigator)
    • 12:39 pm – Tarunendu Mapder, PhD, IU School of Medicine – Innate and Adaptive Immune Response to SARS-CoV-2 Infection Play Major Role in Disease Severity (Investigator)
  • Health Implementation I
    • 12:15 pm – Angela Campbell, MPH, PhD, IU School of Medicine – Pharmacologic Therapy Among Opioid Exposed Infants: Disparities by Race (TL1 Postdoc)
    • 12:21 pm – Andrea Cohee, PhD, RN, Indiana University–Purdue University Indianapolis – Building a Cancer-Related Self-Efficacy Tool for Partners of Breast Cancer Survivors Using Qualitative Interviews (KL2)
    • 12:27 pm – Allyson Dir, PhD, IU School of Medicine – Feasibility of Parent Navigators for Parents of Justice-Involved Youth (KL2)
    • 12:33 pm – Francesca Duncan, MD, MS, IU School of Medicine – Health Disparities in Lung Cancer Diagnosis and Treatment: A Single Center Retrospective Study from a Central Indiana Hospital (TL1 Postdoc)
    • 12:39 pm – Lisa Hayes, JD, R.E.D. (Reaching to End Disparities) Alliance – Tracking the Process of Treatment Seeking in Breast Cancer Patients (Investigator)
  • Health Implementation II
    • 12:15 pm – Monica Kasting, PhD, Purdue University – Developing a Multilevel Intervention to Increase Hepatitis C Virus Screening of Baby Boomers in Primary Care (KL2)
    • 12:21 pm – Nimisha Kumar – Priority-setting for Cochrane Review Updates with Clinicians and Consumers (MedSTAR)
    • 12:27 pm – Jennifer Maratt, MD, IU School of Medicine – Low-risk Adenoma Surveillance Decision-making: Perspectives from Patients and Providers (KL2)
    • 12:33 pm – Janet Panoch, PhD, IU School of Medicine – Doctors and Patients and Parents, Oh My!: A Translational Case Study with Diverse Stakeholders for a Patient Decision Aid from Development to Implementation (Investigator)
    • 12:39 pm – Ebony Williams, MS, IU School of Medicine – Enrollment of Diverse Populations in the INGENIOUS Clinical Trial (TL1 Predoc)
  • Microbiology & Immunology
    • 12:15 pm – Hannah Corman, University of Notre Dame – Investigation of a Series of 1,4-diaryl-pyrazolo-pyridinones as Anti-Leishmanial Agents (TL1 Predoc)
    • 12:21 pm – Heba Ismail, MD, Indiana University–Purdue University Indianapolis – Evaluating the Effect of Prebiotics on the Gut Microbiome Profile and β-cell Function in Newly-Diagnosed Type 1 Diabetes (KL2)
    • 12:27 pm – Xiao Liu, PhD, Purdue University – Computational Model of Ebolavirus Matrix Protein Assembly Phospholipid Influence on Production of Viral Particles (Investigator)
    • 12:33 pm – Badhu Sivasubramaniam, Purdue University – Antimicrobial photodynamic therapy of Staphylococcus aureus using non-iron hemin analogs (Investigator)
    • 12:39 pm – Catherine Weathered, Purdue University – Mycobacterium avium Infection in the Lungs: An Agent-based model showing the Effects of Bacterial Phenotypes and Biofilm (Investigator)
  • Modeling
    • 12:15 pm – Ephrem Abebe, PhD, Purdue University – Medication Use Safety During Care Transitions for Children with Medical Complexity (KL2)
    • 12:21 pm – Blessed Winston Arul Dhas, MD, IU School of Medicine – Population pharmacokinetics of R and S methadone in children undergoing major surgery (Investigator)
    • 12:27 pm – April Savoy, PhD, Indiana University–Purdue University Indianapolis – Closing the Cross-institutional Referral Loop: Assessing consultant notes (KL2)
    • 12:33 pm – David Sohutskay, Purdue University – Computational Modeling of Dermal Replacement Therapy for Difficult-to-Heal Wounds (TL1 Predoc)
    • 12:39 pm – Michael Stokes, Waveform Communication, LLC – Utilization of Speech Analysis as a Diagnostic Tool to Objectively Evaluate Early Signs of Medical Conditions and Recovery (Investigator)
  • Neuroscience I
    • 12:15 pm – Ali Camara, Purdue University – HYPE-mediated AMPylation as a novel therapeutic target for neurodegeneration (TL1 Predoc)
    • 12:21 pm – Jose Chimelisii-Santiago, MS, IU School of Medicine – Gender Differences in Impulsivity on Youth at Risk for Substance Use Disorders (Investigator)
    • 12:27 pm – Justin Couetil, IU School of Medicine – MOBILE clinical trial Autologous Bone Marrow Cell Therapy Reduces Opioid Dependence in Patients with Critical Limb Threatening Ischemia (IMPRS)
    • 12:33 pm – Ryan Kokoska, IU School of Medicine – The Role of Alcohol in Hippocampal Calcium Channel (Cav1.2) expression (IMPRS)
    • 12:39 pm – Edmond Rogers, Purdue University – TBI-on-a-chip: Linking physical impact to neurodegeneration by deciphering primary and secondary injury mechanisms (TL1 Predoc)
  • Neuroscience II 
    • 12:15 pm – Michael Bushey, MD, PhD, IU School of Medicine – Collaborative Care for Opioid Dependence And Pain (CCODAP) (KL2)
    • 12:21 pm – Kimberly Fine, PhD, Indiana University-Bloomington – Association Between Early Prescribed Opioid Initiation and Risk of Suicidal Behavior (TL1 Postdoc)
    • 12:27 pm – Deepa Mathew, PhD, IU School of Medicine – Circadian Rhythm Disruption Results in Visual Dysfunction (Investigator)
    • 12:33 pm – Jheel Patel, IU School of Medicine – Silencing of the neuronal nitric oxide synthase gene in the basolateral amygdala impairs cued fear memory consolidation (TL1 Predoc)
    • 12:39 pm – Daniel Romano, IU School of Medicine – Single-cell RNA-sequencing analysis of human inner ear organoids using AutoClustR: A computational tool for unbiased cell type discovery (MedSTAR)
  • Oncology
    • 12:15 pm – Christina Huang, MS, IU School of Medicine – Simultaneous inhibition of p65 (NF-κB, RelA) and PDK2 Increases Cytotoxicity and Radiation-induced Cell Killing of Pancreatic Adenocarcinoma (MedSTAR)
    • 12:21 pm – Sarah Libring, Purdue University – Mesenchymal Breast Cancer Cells Modulate Extracellular Fibronectin Levels to Enhance Metastatic Outgrowth (TL1 Predoc)
    • 12:27 pm – Kaustabh Sarkar, Purdue University – Radioluminescent nanoparticles for combination chemoradiotherapy of locally advanced head and neck cancers (Investigator)
    • 12:33 pm – Kevin Van der Jeught, PhD, IU School of Medicine – ST2 as checkpoint target for colorectal cancer immunotherapy (Investigator)
    • 12:39 pm – Dhushyanth Viswanath, Purdue University – Bilirubin-Coated Radio-Luminescent Particles for Radiation-Induced Photodynamic Therapy (Investigator)
|2020-09-10T16:05:33-04:00September 3rd, 2020|Comments Off on 2020 Indiana CTSI Annual Meeting poster presentation breakout rooms selected

About the Author: Anna Carrera

Anna Carrera
Anna Carrera is the research communications manager for Indiana University's Precision Health Initiative, IU School of Medicine Research Affairs and the Indiana Clinical and Translational Sciences Institute. She joined the team in June 2019 after working as a TV news reporter for ten years. She loves sharing stories about the great research being done across the state to improve the health of Hoosiers.

Get Involved with Indiana CTSI